Please assess the completion status of the following clinical trial:

Trial Title: ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elective cesarean planned under spinal anesthesia~* Singleton pregnancy~* American Society of Anesthesiologists (ASA) classification score of 2 (or less)~* Gestational age of at least 37 weeks~* Intention to breastfeed infant~Exclusion Criteria:~* Contraindications to neuraxial blockade (such as clinically relevant coagulopathy, recent anticoagulant use, patient refusal, or localized skin infection overlying the site of needle entry)~* Anatomical abnormalities contraindicating spinal or QLB placement~* Received/Conversion to general anesthesia~* Received supplemental parenteral anesthesia (sedation) for any reason (e.g. unanticipated prolonged surgical procedure)~* History of chronic pain~* History of chronic opioid use/abuse~* History of Subutex, methadone, other maintenance therapy

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- ITM + Sham QLB (Type: SHAM_COMPARATOR): Standard spinal with intrathecal morphine for surgical anesthetic with sham saline block. Saline will be administered as a quadratus lumborum block prior to cesarean section.
- ITM + Bupivacaine QLB (Type: EXPERIMENTAL): Standard spinal with intrathecal morphine for surgical anesthetic with ql block with bupivacaine local anesthetic. Interventional drug will be administered prior to cesarean section.

Based on this trial design, predict the completion outcome and termination type (if applicable).